Roton Capital

Roton Capital is a Chinese venture capital firm specializing in equity investment and management. The firm is headquartered in Beijing, with additional offices in Suzhou and Hong Kong. It is recognized as a venture capital demonstration enterprise in Jiangsu Province. The firm's team comprises experienced investment bankers and former directors of investment firms. They offer services such as IPO, M&A, restructuring consulting, management consulting, capital operation planning, and cross-border business consulting. Their expertise enables them to accurately assess industry development trends and the feasibility of target companies' securitization. With a core philosophy of integrity, professionalism, cooperation, and innovation, Roton Capital focuses on sectors including medical health, clean energy, and advanced manufacturing. Their mission is to improve resource allocation efficiency and assist invested enterprises in achieving success. Roton Capital has made 20 investments, with its latest in Sinoscience Clean Energy Technology on February 1, 2026. Their portfolio includes companies like EastonBio, Chengdu Shengnuo Biopharm Co., Ltd., Inner Mongolia Furui Medical Science Co., Ltd., Neuracle, Suzhou Pharmavan, Canton Biologics Co., Ltd., Suzhou Thinkre New Material Co., Ltd., MedMind Technology Co., Ltd., PrecisionBio, Platinum Hydrogen, and Soft Carbon. The firm maintains strategic cooperation relationships with over twenty well-known listed companies, enhancing its resource integration capabilities. This extensive network supports their investment activities and provides stable and reliable exit channels for their investments. Roton Capital's investment approach is grounded in industry research, focusing on unmet industry needs and outstanding entrepreneurial talents. They emphasize value investing and aim to establish industry moats in high-tech sectors. Their strong resource integration capabilities and extensive project sourcing network further bolster their investment strategy. Overall, Roton Capital strives to become an outstanding private equity management institution, leveraging its professional team and strategic partnerships to support the growth and success of its portfolio companies.

Innovative business models, Scalable growth potential, Strong management teams, Alignment with firm's investment philosophy